🚀 𝗡𝗲𝘄 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻! 🚀. Excited to share the latest ShortCut publication: “Leaflet Modification During Transcatheter Aortic Valve-in-Valve Replacement - Imaging Guidance for the ShortCut Procedure”. As valve-in-valve procedures become more common, coronary.

Don’t miss the Live ShortCut Case Presentation by Dr. Philippe Généreux from Morristown Medical Center tomorrow at NY Valves 2025!. 🗓️ Friday, June 27th .🕐 13:30 - 14:00 ET .📍 iCOACH, Room 411, Summit Hall, Level 4. @PhilGenereuxMD @crfheart .#PiCardia #ShortCut #TAVI #TAVR

Join us at NY Valves 2025! 🗽. Discover the latest on #ShortCut and the evolving landscape of leaflet modification, featuring presentations by leading experts. 📍 New York City.📅 Don’t miss these key leaflet modification sessions!. @PhilGenereuxMD, @dannydvir , @TheLADoctor,

RT @cardiacinterv: Pi-Cardia’s ShortCut Leaflet Modification Device for TAVR Used in First Commercial Procedures | @Pi_Cardia https://t.co….

ShortCut™ is transforming complex TAVR procedures with its innovative approach to leaflet modification. ✨. Esteemed cardiologists 👨‍⚕️ Dr. Hemal Gada, Dr. Philippe Généreux, and Dr. Thomas E. Waggoner, DO, FACC, FSCAI, FSVM, RPVI share their expert insights on this advancement.

🚨 𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦 🚨. 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁 𝗶𝘀 𝗼𝗳𝗳 𝘁𝗼 𝗮𝗻 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 𝘀𝘁𝗮𝗿𝘁 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦! 🚀. The first week of commercialization demonstrated strong demand, with leading structural heart centers successfully treating patients with #ShortCut,.

ShortCut Continued Access Study Completes Enrollment! 🎉. An outstanding ShortCut case was performed by Dr. @SaibalKar, Dr. @Greg Fontana, and the #HeartTeam at @Los_RoblesCA. The team successfully split both the LCC and RCC leaflets in just 20 minutes, enabling a safe TAVR with

✨ What an incredible PCR London Valves! ✨ . Three days filled with meaningful innovation and education with the latest advancements in the field. We are thrilled to be part of a community pushing boundaries and improving patient outcomes. A huge thank you to our key experts for

Heading to PCR London Valves! 🇬🇧. Excited to join this global cardiology community and see the latest advancements in leaflet modification 💡. @PCRonline #PCRLV2024 #PCRLondonValves.#PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation

What a fantastic week at #TCT2024! 🎉. It was a great opportunity to connect with friends and colleagues, and the excitement surrounding ShortCut and its recent FDA clearance was truly inspiring 🌟. A sincere thank you to our key experts for their outstanding presentations on

📣 𝗛𝗲𝗮𝗿 𝗗𝗿. 𝗠𝗮𝗿𝘁𝗶𝗻 𝗕. 𝗟𝗲𝗼𝗻 𝗱𝗶𝘀𝗰𝘂𝘀𝘀 𝘁𝗵𝗲 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝗰𝗲 𝗼𝗳 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁™, 𝗮 𝗴𝗿𝗼𝘂𝗻𝗱𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗱𝗲𝘃𝗶𝗰𝗲 𝗱𝗲𝘀𝗶𝗴𝗻𝗲𝗱 𝗳𝗼𝗿 𝗹𝗲𝗮𝗳𝗹𝗲𝘁 𝘀𝗽𝗹𝗶𝘁𝘁𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗶𝘁𝘀 𝗿𝗼𝗹𝗲 𝗶𝗻 𝗲𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝘁𝗵𝗲.

Congratulations to the Heart Team at the @UMich for including their first patient in the #ShortCut Continued Access Study! 👏 . The patient had a failed Trifecta valve and was at high risk for obstruction of both the RCC and LCC leaflets. The ShortCut procedure went smoothly with

Want to learn more about leaflet modification? Make sure to mark your calendars with the Pi-Cardia presentations at hashtag#TCT2024 💡 . Looking forward to seeing everyone in Washington DC! 🏛️. @DvirDanny @PradeepYadavMD @PhilGenereuxMD.#PiCardia #ShortCut #TAVI #TAVR

📣 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁 – 𝗧𝗵𝗲 𝗙𝗶𝗿𝘀𝘁 𝗗𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝗟𝗲𝗮𝗳𝗹𝗲𝘁 𝗠𝗼𝗱𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗶𝘀 𝗡𝗼𝘄 𝗙𝗗𝗔 𝗖𝗹𝗲𝗮𝗿𝗲𝗱!. Addressing lifetime management of aortic stenosis with a safe, simple and effective solution 🫀. #PiCardia #ShortCut

RT @cardiacinterv: Pi-Cardia’s ShortCut Leaflet Modification Device for TAVR Cleared by FDA .

RT @PradeepYadavMD: Pi-Cardia Shortcut FDA approved! What a great news! Best dedicated device to make the procedure simpler and more access….

RT @didier_tchetche: Lifetime management of aortic stenosis calls for leaflet modification solutions like ShortCut™ to ensure that we are c….